The project to use the Quantum Molecular Resonance in Aesthetic Medicine through the development of Rexon-age, and now with its evolution, Rexon-age 2, arises from an intense scientific research, carried out both within the Company and in close collaboration with the Department of Physiology and Human Anatomy of the University of Padua.
Thanks to the fundamental contribution of University, it was possible to understand the principles of action underlying the cell stimulation promoted by Rexon-Age 2.
Unlike many devices on the market today, which only produce a simple heating of tissues due to the Joule effect, Rexon-Age 2 promotes cellular stimulation in a very peculiar way, while keeping the temperature low and therefore avoiding risks and side effects that its excessive increase could entail.
The very high-frequency electric fields with Molecular Quantum Resonance spectrum, stimulate the production from the fibroblasts of new collagen and elastin fibres; such proteins are the fundamental constituents of the extracellular matrix. The quantity of these proteins in the dermis determines the level of tone and elasticity.
As we age, the density of these proteins tends to steadily decrease (it is estimated that the reduction, in adulthood, is about 1% per year). From this derive the well-known signs of the process of skin ageing, such as the formation and deepening of wrinkles, cutaneous sagging, the reduction of elasticity and tone of the dermis.
Through the treatment with Rexon-Age 2, the skin is stimulated to increase the production of these important proteins constituting the supporting structure of our skin. This happens both through a stimulating action aimed on the fibroblasts to produce more proteins and through also the increase of fibroblasts density, by acting on the adult stem cells which are located in the basal lamina.
The medical device REXONAGE 2, acting more on the surface, favours the regeneration of epithelial and muscular tissues damaged by ageing (increase and remodelling of collagen type 1, 2 and 3 and of elastin).
The QMR technology used on all Telea medical devices, is tested for biological safety with a study conducted on 28,000 genes that confirmed the effective regeneration and biological safety aimed at ensuring the absence of cellular damage in the patient.